Principal Scientist, Molecular Discovery @ Epizyme (January 2011 - September 2013)
Manager, Discovery Chemistry @ Antisoma (June 2008 - December 2010)
Senior Scientist @ Xanthus Pharmaceuticals (Acquired by Antisoma) (November 2006 - May 2008)
Research Chemist @ (June 2006 - November 2006)
Research Scientist @ Cyclacel Pharmaceuticals, Inc. (November 2001 - December 2005)
Associate Scientist @ Solvay Interox (March 1996 - May 1997)
Kenneth Duncan Education
University of Strathclyde
PhD
1998-2001
University of Strathclyde
BSc (Hons)
1993-1998
Kenneth Duncan Skills
CRO
Chemistry
Clinical Development
Communication
Department leadership
Drug Design
Drug Development
Drug Discovery
Drug Discovery & Development
Executive Management
In Vivo
Leadership
Lifesciences
Medicinal Chemistry
Molecular Modeling
Oncology
Organic Chemistry
Organic Synthesis
Patent Law
Program Management
Strategic Alliances
Technical Writing
Technology Transfer
Research
Molecular
Wood
Project Management
Strategy
Kenneth Duncan Summary
Kenneth Duncan, based in United States, is currently a SVP, Chemistry at Stealth Mode Biotech. Kenneth Duncan brings experience from previous roles at KDDiscovery LLC., Accent Therapeutics, Inc. and Epizyme. Kenneth Duncan holds a 1998 - 2001 PhD @ University of Strathclyde. With a robust skill set that includes CRO, Chemistry, Clinical Development, Communication, Department leadership and more. Kenneth Duncan has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Kenneth Duncan?
Find contact details for 700 million professionals.